|
MCPH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.31600000014198E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.04640000009715E-07 |
| Normal-vs-Stage2 |
6.156500E-04 |
| Normal-vs-Stage3 |
8.181200E-04 |
| Normal-vs-Stage4 |
3.217900E-04 |
| Stage1-vs-Stage2 |
8.797000E-01 |
| Stage1-vs-Stage3 |
5.659200E-01 |
| Stage1-vs-Stage4 |
6.287200E-01 |
| Stage2-vs-Stage3 |
7.243600E-01 |
| Stage2-vs-Stage4 |
5.252000E-01 |
| Stage3-vs-Stage4 |
3.350000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.15579999979832E-07 |
| Normal-vs-AfricanAmerican |
2.05709999999693E-05 |
| Normal-vs-Asian |
9.78379999999612E-05 |
| Caucasian-vs-AfricanAmerican |
7.282000E-01 |
| Caucasian-vs-Asian |
2.465200E-01 |
| AfricanAmerican-vs-Asian |
2.121600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65459999537754E-08 |
| Normal-vs-Female |
8.421000E-03 |
| Male-vs-Female |
1.424460E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.774610E-04 |
| Normal-vs-Extreme_Weight |
4.21189999988414E-07 |
| Normal-vs-Obese |
5.435000E-04 |
| Normal-vs-Extreme_Obese |
1.380080E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.737000E-01 |
| Normal_Weight-vs-Obese |
4.762800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.713600E-01 |
| Extreme_Weight-vs-Obese |
1.856570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.962000E-01 |
| Obese-vs-Extreme_Obese |
2.396400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.724800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.15320000000108E-05 |
| Normal-vs-Age(61-80Yrs) |
2.37039999850808E-08 |
| Normal-vs-Age(81-100Yrs) |
1.67831999999812E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.727800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.429620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.230200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.927500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.106150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.327000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.14029999781695E-08 |
| Normal-VS-Type2 PRCC |
2.6223000000325E-06 |
| Normal-VS-KIRP CIMP |
9.066400E-01 |
| Normal-VS-Unclassified PRCC |
3.741900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.686800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.562770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.377400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.996390E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.053600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.782050E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.3336999827327E-10 |
| Normal-vs-N1 |
1.094370E-01 |
| Normal-vs-N2 |
3.423800E-02 |
| N0-vs-N1 |
3.683900E-02 |
| N0-vs-N2 |
4.784000E-01 |
| N1-vs-N2 |
5.913400E-01 |
|
|
